DOSE OF REALITY: PATENT HEARINGS OFFER OPPORTUNITY TO HOLD BIG PHARMA ACCOUNTABLE FOR ANTI-COMPETITIVE PRACTICES
Jun 22, 2022
Lawmakers Can Highlight Tactics Designed to Block More Affordable Alternatives… Read More
© 2026 CSRXP- All Rights Reserved
Blog Posts
SECOND OPINION: PHRMA REDUXES DEBUNKED BLAME GAME RHETORIC IN NEW AD CAMPAIGN
Jun 17, 2022
Big Pharma Trots Out Tired, Dishonest Arguments Designed to Evade… Read More
THEY SAID IT! ANTITRUST EXPERTS AND OFFICIALS SHINE A LIGHT ON BIG PHARMA’S ANTI-COMPETITIVE PLAYBOOK
Jun 16, 2022
Federal Trade Commission Workshop Highlights How Brand Name Drug Companies… Read More
DOSE OF REALITY: BIG PHARMA TARGETS MERGERS AND ACQUISITIONS TO KEEP PRICES HIGH, EXTEND MONOPOLIES AND BOOST PROFITS
Jun 13, 2022
FTC Workshop Can Highlight How Brand Name Drug Companies Employ… Read More
BIG PHARMA WATCH: PHARMACEUTICAL COMPANIES HIKED LAUNCH PRICES BY 20 PERCENT EVERY YEAR FOR 14 YEARS
Jun 9, 2022
Nearly Half of All New Brand Name Drugs Cost More Than $150,000 Per Year In… Read More
BIG PHARMA WATCH: REPORTS SHOW BIG PHARMA HAD ANOTHER BANNER YEAR IN 2021
Jun 3, 2022
Brand Name Drug Companies Posted Massive Profit Growth and Invested Heavily in… Read More
BIG PHARMA WATCH: STUDY FINDS BIG PHARMA TARGETS MOST PROFITABLE DRUGS FOR NEW FORMULATIONS TO BLOCK COMPETITION
May 25, 2022
Brand Name Drug Companies Four Times as Likely to Reformulate Blockbuster… Read More
BIG PHARMA WATCH: NEW ANALYSIS FINDS BIG PHARMA REAPS BIG MULTIPLES FROM MEDICARE SPENDING ON TOP DRUGS
May 13, 2022
Part D Spending on 10 Most Popular Medications Over Five Years Averages Five… Read More
BIG PHARMA EARNINGS WATCH: BRISTOL-MYERS SQUIBB, ABBVIE, ASTRAZENECA AND PFIZER
May 6, 2022
Another Round of Big Pharma Giants Beat Wall Street Expectations In Q1 After… Read More
DOSE OF REALITY: SENATE COMMERCE HEARING OPPORTUNITY FOR LAWMAKERS TO HOLD BIG PHARMA ACCOUNTABLE
May 3, 2022
Lawmakers Should Focus Attention on Brand Name Drug Companies’ Egregious… Read More
BIG PHARMA EARNINGS WATCH: NOVARTIS, GLAXOSMITHKLINE, AMGEN, ROCHE
Apr 29, 2022
Big Pharma Giants Repeatedly Hike Prices and Continue to Beat Wall Street… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Apr 20, 2022
J&J Beats Q1 Earnings Expectations, Announces Dividend Increase After… Read More